Physician profile
Christopher D Galli
NPI 1740785021
$14,446.26
in general payments reported to CMS, 2019-2025
40 companies · $1,566 in 2025
The $1,566 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2021: $2,345 · 2022: $5,060 · 2023: $3,326 · 2024: $1,714 · 2025: $1,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,113 · Travel and Lodging: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,113.02 |
| Travel and Lodging | $1,492.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,823.99 | 2021-2025 | Prostep, Augment Injectable, Actishield |
| Paragon 28, INC. | $2,519.58 | 2022-2025 | Portfolio, Precision Mis Bunion |
| Bioventus LLC | $467.98 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Sportstek Medical, INC | $436.00 | 2019 | |
| Smith+Nephew, INC. | $342.01 | 2021-2025 | Evos, Renasys, Large Qwix |
| Globus Medical, INC. | $229.42 | 2023-2025 | Senza, Mini Fragment System, Ankle Fracture System |
| Orthofix Medical, INC. | $217.89 | 2023-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $187.94 | 2021-2025 | Motoband |
| Trilliant Surgical LLC. | $179.92 | 2023-2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Ets Wound Care LLC | $152.23 | 2025 | Mirragen Advanced Wound Matrix |
| Treace Medical Concepts, INC. | $142.59 | 2023-2025 | |
| Avita Medical Americas, LLC | $142.15 | 2024 | |
| Nevro Corp. | $137.50 | 2021-2022 | |
| Next Science LLC | $129.00 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $128.07 | 2023 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $126.63 | 2024-2025 | |
| Biotissue Holdings INC. | $108.78 | 2023 | |
| Cardiovascular Systems INC. | $85.21 | 2022 | |
| Medshape, INC. | $79.58 | 2025 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm, Dynanail |
| Linvatec Corporation | $75.47 | 2025 | Biobrace 23mm, Anchor |
| Integra Lifesciences Corporation | $74.27 | 2021 | |
| Zimvie INC. | $70.87 | 2022-2023 | |
| Kerecis Limited | $65.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Exactech, INC. | $62.08 | 2024 | |
| Restor3d, INC. | $58.49 | 2025 | |
| Medtronic, INC. | $44.17 | 2022-2023 | Intellis Adaptivestim |
| Hartmann USA, INC. | $42.08 | 2022-2023 | Zetuvit Plus |
| Horizon Therapeutics Plc | $38.14 | 2023 | Krystexxa |
| Curonix LLC | $32.33 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vericel Corporation | $25.74 | 2023 | Maci |
| Convatec INC. | $24.44 | 2023 | |
| Paratek Pharmaceuticals, INC. | $24.36 | 2025 | Nuzyra |
| Amgen INC. | $24.32 | 2025 | Krystexxa |
| Ethicon US, LLC | $23.64 | 2022 | |
| Heron Therapeutics, INC. | $22.19 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.54 | 2025 | Jublia |
| Novastep INC. | $20.88 | 2025 | Nexis |
| Averitas Pharma INC. | $20.57 | 2023 | Qutenza |
| Fusion Orthopedics USA, LLC | $20.04 | 2024 | |
| Melinta Therapeutics, LLC | $18.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Galli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.